GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theranexus SA (XPAR:ALTHX) » Definitions » 6-1 Month Momentum %

Theranexus (XPAR:ALTHX) 6-1 Month Momentum % : -12.94% (As of May. 22, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Theranexus 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-22), Theranexus's 6-1 Month Momentum % is -12.94%.

The industry rank for Theranexus's 6-1 Month Momentum % or its related term are showing as below:

XPAR:ALTHX's 6-1 Month Momentum % is ranked worse than
58.73% of 1529 companies
in the Biotechnology industry
Industry Median: -5.5 vs XPAR:ALTHX: -12.94

Competitive Comparison of Theranexus's 6-1 Month Momentum %

For the Biotechnology subindustry, Theranexus's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theranexus's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theranexus's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Theranexus's 6-1 Month Momentum % falls into.



Theranexus  (XPAR:ALTHX) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Theranexus  (XPAR:ALTHX) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Theranexus 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Theranexus's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Theranexus (XPAR:ALTHX) Business Description

Traded in Other Exchanges
Address
60 avenue Rockefeller, Pepiniere Laennec, Lyon, FRA, 69008
Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. The company's therapeutics platform is based on simultaneously targeting neurons and glial cells by creating and developing innovative combinations of two distinct drugs: a CNS drug targeting neuronal activity; and a drug targeting glial cells. The drug candidates of the organization are THN102 to treat excessive daytime sleepiness in Parkinson's disease, THN201 for the treatment of neurocognitive disorders in Alzheimer's disease and THN101 for neuropathic pain.

Theranexus (XPAR:ALTHX) Headlines

No Headlines